AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $0
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| FPC | Ann: Update - Notification of buy-back - FPC | 04/02/25 | 0 | 1 | |||
|
|||||||
| FPC | Ann: Net Tangible Asset Backing | 16/04/18 | 1 | 172 | |||
|
|||||||
| FPC | Ann: Net Tangible Asset Backing | 14/03/18 | 0 | 182 | |||
|
|||||||
| FPC | Ann: ASX Notice | 13/03/18 | 17 | 6.9K | |||
|
|||||||
See All Discussions
ASX News